To determine the potential role of RBP2 in ALL, we investigated the expression of RBP2 in bone marrow samples from 42 newly diagnosed adult patients (de novo ALL), 36 patients in complete remission (ALL-CR) and 9 relapsed adult patients (ALL-relapse). Here, RBP2 is linked to acute lymphoblastic leukemia.